Loading...

Roselle Abraham, MD

Title(s)Associate Professor, Medicine
SchoolSchool of Medicine
Address555 Mission Bay Blvd South
San Francisco CA 94158
Phone415-502-3911
vCardDownload vCard

    Collapse Overview 
    Collapse Overview
    CLINICAL INTERESTS: Dr. Roselle Abraham is a cardiologist with expertise in the treatment of patients with hypertrophic cardiomyopathy.

    RESEARCH INTERESTS: Dr. Roselle Abraham is a physician scientist with a background in electrophysiology, imaging and stem cell research. She is using multi-modality imaging for risk stratification of atrial and ventricular arrhythmias. The overall goal of her research program is to use a combination of multi-modality clinical imaging and studies in model systems to tailor therapies for patients with hypertrophic cardiomyopathy.

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. A variable resolution approach for improved acquisition of hyperpolarized 13 C metabolic MRI. Magn Reson Med. 2020 12; 84(6):2943-2952. Gordon JW, Autry AW, Tang S, Graham JY, Bok RA, Zhu X, Villanueva-Meyer JE, Li Y, Ohilger MA, Abraham MR, Xu D, Vigneron DB, Larson PEZ. PMID: 32697867.
      View in: PubMed   Mentions:    Fields:    
    2. Correction to: Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2019 Aug; 26(4):1254. PMID: 29423907.
      View in: PubMed   Mentions:    Fields:    
    3. Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model). Am J Cardiol. 2019 05 15; 123(10):1681-1689. Bhattacharya M, Lu DY, Kudchadkar SM, Greenland GV, Lingamaneni P, Corona-Villalobos CP, Guan Y, Marine JE, Olgin JE, Zimmerman S, Abraham TP, Shatkay H, Abraham MR. PMID: 30952382.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    4. Allele-specific differences in transcriptome, miRNome, and mitochondrial function in two hypertrophic cardiomyopathy mouse models. JCI Insight. 2018 03 22; 3(6). PMID: 29563334.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    5. Clinical Outcomes in Patients With Nonobstructive, Labile, and Obstructive Hypertrophic Cardiomyopathy. J Am Heart Assoc. 2018 02 25; 7(5). Lu DY, Pozios I, Haileselassie B, Ventoulis I, Liu H, Sorensen LL, Canepa M, Phillip S, Abraham MR, Abraham TP. PMID: 29478967.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    6. Rest and Stress Longitudinal Systolic Left Ventricular Mechanics in Hypertrophic Cardiomyopathy: Implications for Prognostication. J Am Soc Echocardiogr. 2018 05; 31(5):578-586. Pozios I, Pinheiro A, Corona-Villalobos C, Sorensen LL, Dardari Z, Liu HY, Cresswell K, Phillip S, Bluemke DA, Zimmerman SL, Abraham MR, Abraham TP. PMID: 29426649.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    7. Stress Myocardial Blood Flow Heterogeneity Is a Positron Emission Tomography Biomarker of Ventricular Arrhythmias in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2018 05 01; 121(9):1081-1089. Lu DY, Yalçin H, Yalçin F, Zhao M, Sivalokanathan S, Valenta I, Tahari A, Pomper MG, Abraham TP, Schindler TH, Abraham MR. PMID: 29678336.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    8. Comparison of two software systems for quantification of myocardial blood flow in patients with hypertrophic cardiomyopathy. J Nucl Cardiol. 2019 08; 26(4):1243-1253. Yalcin H, Valenta I, Zhao M, Tahari A, Lu DY, Higuchi T, Yalcin F, Kucukler N, Soleimanifard Y, Zhou Y, Pomper MG, Abraham TP, Tsui B, Lodge MA, Schindler TH, Roselle Abraham M. PMID: 29359273.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    9. E/e' ratio and outcome prediction in hypertrophic cardiomyopathy: the influence of outflow tract obstruction. Eur Heart J Cardiovasc Imaging. 2018 01 01; 19(1):101-107. Lu DY, Haileselassie B, Ventoulis I, Liu HY, Liang HY, Pozios I, Canepa M, Phillip S, Abraham MR, Abraham T. PMID: 28977350.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    10. Impact of peak provoked left ventricular outflow tract gradients on clinical outcomes in hypertrophic cardiomyopathy. Int J Cardiol. 2017 Sep 15; 243:290-295. PMID: 28747034.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    11. Plasma homocysteine levels associated with a corrected QT interval. BMC Cardiovasc Disord. 2017 07 11; 17(1):182. PMID: 28693429.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    12. Structural and Functional Correlates of Myocardial T1 Mapping in 321 Patients With Hypertrophic Cardiomyopathy. J Comput Assist Tomogr. 2017 Jul/Aug; 41(4):653-660. PMID: 27997439.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    13. Role of Global Longitudinal Strain in Predicting Outcomes in Hypertrophic Cardiomyopathy. Am J Cardiol. 2017 Aug 15; 120(4):670-675. PMID: 28687124.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    14. Exercise-QTc is associated with diffuse interstitial fibrosis reflected by lower approximated T1 relaxation time in hypertrophic cardiomyopathy patients. J Electrocardiol. 2017 Jul - Aug; 50(4):484-490. Corona-Villalobos CP, Saha S, Pozios I, Hurtado-de-Mendoza Paz D, Sorensen L, Gonzalez Cordoba J, Dolores-Cerna K, Kamel IR, Mormontoy Laurel W, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR. PMID: 28292523.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Diffuse interstitial fibrosis assessed by cardiac magnetic resonance is associated with dispersion of ventricular repolarization in patients with hypertrophic cardiomyopathy. J Arrhythm. 2017 Jun; 33(3):201-207. Hurtado-de-Mendoza D, Corona-Villalobos CP, Pozios I, Gonzales J, Soleimanifard Y, Sivalokanathan S, Montoya-Cerrillo D, Vakrou S, Kamel I, Mormontoy-Laurel W, Dolores-Cerna K, Suarez J, Perez-Melo S, Bluemke DA, Abraham TP, Zimmerman SL, Abraham MR. PMID: 28607615.
      View in: PubMed   Mentions:
    16. Safety profile and utility of treadmill exercise in patients with high-gradient hypertrophic cardiomyopathy. Am Heart J. 2017 02; 184:47-54. PMID: 27892886.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    17. Effect of Diffuse Subendocardial Hypoperfusion on Left Ventricular Cavity Size by 13N-Ammonia Perfusion PET in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2016 Dec 15; 118(12):1908-1915. PMID: 27771003.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    18. Metabolism rather than obesity is associated with ischemic stroke: a cross-sectional study in rural Northeastern China. Springerplus. 2016; 5(1):1419. PMID: 27625973.
      View in: PubMed   Mentions:
    19. The Relation of Moderate Alcohol Consumption to Hyperuricemia in a Rural General Population. Int J Environ Res Public Health. 2016 07 20; 13(7). PMID: 27447659.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    20. Common miR-590 Variant rs6971711 Present Only in African Americans Reduces miR-590 Biogenesis. PLoS One. 2016; 11(5):e0156065. PMID: 27196440.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansCells
    21. Left ventricular wall thickness in patients with hypertrophic cardiomyopathy: a comparison between cardiac magnetic resonance imaging and echocardiography. Int J Cardiovasc Imaging. 2016 Jun; 32(6):945-54. PMID: 26896038.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    22. Echocardiographic Characterization of a Murine Model of Hypertrophic Obstructive Cardiomyopathy Induced by Cardiac-specific Overexpression of Epidermal Growth Factor Receptor 2. Comp Med. 2016; 66(4):268-77. PMID: 27538857.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimalsCells
    23. Shape analysis of hypertrophic and hypertensive heart disease using MRI-based 3D surface models of left ventricular geometry. Med Image Anal. 2016 Apr; 29:12-23. PMID: 26766206.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    24. Comparison of Outcomes in Patients With Nonobstructive, Labile-Obstructive, and Chronically Obstructive Hypertrophic Cardiomyopathy. Am J Cardiol. 2015 Sep 15; 116(6):938-44. PMID: 26239580.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    25. Late gadolinium enhancement confined to the right ventricular insertion points in hypertrophic cardiomyopathy: an intermediate stage phenotype? Eur Heart J Cardiovasc Imaging. 2016 Mar; 17(3):293-300. PMID: 26077330.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    26. Apparent left ventricular cavity dilatation during PET/CT in hypertrophic cardiomyopathy: Clinical predictors and potential mechanisms. J Nucl Cardiol. 2016 12; 23(6):1304-1314. PMID: 25989730.
      View in: PubMed   Mentions: 8     Fields:    Translation:Humans
    27. Utilizing ECG-Based Heartbeat Classification for Hypertrophic Cardiomyopathy Identification. IEEE Trans Nanobioscience. 2015 Jul; 14(5):505-12. PMID: 25915962.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    28. Exercise heart rates in patients with hypertrophic cardiomyopathy. Am J Cardiol. 2015 Apr 15; 115(8):1144-1150. PMID: 25746289.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    29. Identifying Hypertrophic Cardiomyopathy Patients by Classifying Individual Heartbeats from 12-lead ECG Signals. Proceedings (IEEE Int Conf Bioinformatics Biomed). 2014 Nov; 2014:224-229. PMID: 25737801.
      View in: PubMed   Mentions:
    30. Age-related changes in familial hypertrophic cardiomyopathy phenotype in transgenic mice and humans. J Huazhong Univ Sci Technolog Med Sci. 2014 Oct; 34(5):634-639. PMID: 25318870.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansAnimals
    31. Hypertrophic cardiomyopathy: a heart in need of an energy bar? Front Physiol. 2014; 5:309. PMID: 25191275.
      View in: PubMed   Mentions:
    32. Comparison of clinical presentation, left ventricular morphology, hemodynamics, and exercise tolerance in obese versus nonobese patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013 Oct 15; 112(8):1182-9. PMID: 24079444.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    33. Electromechanical relationship in hypertrophic cardiomyopathy. J Cardiovasc Transl Res. 2013 Aug; 6(4):604-15. PMID: 23771430.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    34. Creatine kinase adenosine triphosphate and phosphocreatine energy supply in a single kindred of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2013 Sep 15; 112(6):861-6. PMID: 23751935.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    35. Relationship of delayed enhancement by magnetic resonance to myocardial perfusion by positron emission tomography in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging. 2013 Mar 01; 6(2):210-7. PMID: 23418294.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    36. In hypertrophic cardiomyopathy reduction of relative resting myocardial blood flow is related to late enhancement, T2-signal and LV wall thickness. PLoS One. 2012; 7(7):e41974. PMID: 22860042.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    37. Comparison and effectiveness of regadenoson versus dipyridamole on stress electrocardiographic changes during positron emission tomography evaluation of patients with hypertrophic cardiomyopathy. Am J Cardiol. 2012 Oct 01; 110(7):1033-9. PMID: 22748357.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    38. Cardiac MRI evaluation of hypertrophic cardiomyopathy: left ventricular outflow tract/aortic valve diameter ratio predicts severity of LVOT obstruction. J Magn Reson Imaging. 2012 Sep; 36(3):598-603. PMID: 22549972.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    39. PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathy. J Nucl Med. 2012 Mar; 53(3):407-14. PMID: 22315440.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    40. Constitutive HIF-1a expression blunts the beneficial effects of cardiosphere-derived cell therapy in the heart by altering paracrine factor balance. J Cardiovasc Transl Res. 2011 Jun; 4(3):363-72. Bonios M, Chang CY, Terrovitis J, Pinheiro A, Barth A, Dong P, Santaularia M, Foster DB, Raman V, Abraham TP, Abraham MR. PMID: 21538185.
      View in: PubMed   Mentions: 7     Fields:    Translation:HumansAnimalsCells
    41. Anatomy of the tendinous cords of the interventricular septum of the human heart. Ital J Anat Embryol. 2008 Oct-Dec; 113(4):273-9. Wafae N, Ruiz CR, Abraham M, Freire CH, Demarchi GT, Wafae GC. PMID: 19507468.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    42. Stem cell: "KANT" you see it? J Cardiovasc Transl Res. 2008 Jun; 1(2):103-5. Bonios MJ, Terrovitis JV, Abraham MR. PMID: 20559903.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimalsCells
    43. Angiotensin-converting enzyme genotype modulates pulmonary function and exercise capacity in treated patients with congestive stable heart failure. Circulation. 2002 Oct 01; 106(14):1794-9. Abraham MR, Olson LJ, Joyner MJ, Turner ST, Beck KC, Johnson BD. PMID: 12356632.
      View in: PubMed   Mentions: 11     Fields:    Translation:HumansCTClinical Trials
    Roselle's Networks
    Concepts (211)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (9)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _
    ↑